158 related articles for article (PubMed ID: 15200500)
21. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
22. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
Reddy PH; Beal MF
Brain Res Brain Res Rev; 2005 Nov; 49(3):618-32. PubMed ID: 16269322
[TBL] [Abstract][Full Text] [Related]
23. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
[TBL] [Abstract][Full Text] [Related]
24. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
Blain JF; Poirier J
Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
27. Isoprenoids and Alzheimer's disease: a complex relationship.
Cole SL; Vassar R
Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
[TBL] [Abstract][Full Text] [Related]
28. Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease?
Bohr IJ
Lipids Health Dis; 2005 Jun; 4():13. PubMed ID: 15949039
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach.
Candore G; Balistreri CR; Grimaldi MP; Listì F; Vasto S; Chiappelli M; Licastro F; Colonna-Romano G; Lio D; Caruso C
Mech Ageing Dev; 2007 Jan; 128(1):67-75. PubMed ID: 17116319
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease: brain expression of a metabolic disorder?
Merlo S; Spampinato S; Canonico PL; Copani A; Sortino MA
Trends Endocrinol Metab; 2010 Sep; 21(9):537-44. PubMed ID: 20541952
[TBL] [Abstract][Full Text] [Related]
31. Inflammation, genes and zinc in Alzheimer's disease.
Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
[TBL] [Abstract][Full Text] [Related]
32. Environmental and dietary risk factors in Alzheimer's disease.
Dosunmu R; Wu J; Basha MR; Zawia NH
Expert Rev Neurother; 2007 Jul; 7(7):887-900. PubMed ID: 17610395
[TBL] [Abstract][Full Text] [Related]
33. [Genes in Alzheimer's disease].
Hoenicka J
Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
[TBL] [Abstract][Full Text] [Related]
34. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.
Bertram L; Tanzi RE
Nat Rev Neurosci; 2008 Oct; 9(10):768-78. PubMed ID: 18802446
[TBL] [Abstract][Full Text] [Related]
35. Methylene blue and Alzheimer's disease.
Oz M; Lorke DE; Petroianu GA
Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
[TBL] [Abstract][Full Text] [Related]
36. Plasma cholesterol and risk for late-onset Alzheimer's disease.
Cedazo-Mínguez A; Ismail MA; Mateos L
Expert Rev Neurother; 2011 Apr; 11(4):495-8. PubMed ID: 21469922
[TBL] [Abstract][Full Text] [Related]
37. Imbalanced cholesterol metabolism in Alzheimer's disease.
Xue-Shan Z; Juan P; Qi W; Zhong R; Li-Hong P; Zhi-Han T; Zhi-Sheng J; Gui-Xue W; Lu-Shan L
Clin Chim Acta; 2016 May; 456():107-114. PubMed ID: 26944571
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's Disease Risk Genes and Lipid Regulators.
El Gaamouch F; Jing P; Xia J; Cai D
J Alzheimers Dis; 2016 Apr; 53(1):15-29. PubMed ID: 27128373
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.
Lukiw WJ; Pappolla M; Pelaez RP; Bazan NG
Cell Mol Neurobiol; 2005 Jun; 25(3-4):475-83. PubMed ID: 16075376
[TBL] [Abstract][Full Text] [Related]
40. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease.
Han X
Curr Alzheimer Res; 2005 Jan; 2(1):65-77. PubMed ID: 15977990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
